HSPH1 and metastatic neoplasm: Concerning metastatic tumors (n = 59), rates of death did not differ according to HSP110 T17 deletion size (p = 0.21) or HSP110 expression (p = 0.23), and OS did not differ according to the size of HSP110 T17 deletion (p = 0.91) or HSP110 expression (p = 0.15).